Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanakin Technology is a German medical technology company specializing in autologous cytokine therapy (ACT). The company's core product is a specialized syringe system that enables the production of an autologous serum rich in anti-inflammatory cytokines, specifically Interleukin-1 receptor antagonists (IL-1Ra), from a patient's own blood. This serum is used to treat inflammatory conditions such as osteoarthritis, chronic back pain, and sports-related injuries by naturally inhibiting the inflammatory process. Sanakin's technology is widely utilized in orthopedic and regenerative medicine clinics across Europe and other international markets as a biological alternative to traditional pharmacological treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanakin Technology.